Common Errors And Risk Control in Breast Biopsy Needle Repositioning Operations

https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812

Although breast biopsy needles are becoming increasingly user-friendly in design, errors in the repositioning process remain a significant cause of sampling failure, tissue damage, and even medical disputes in actual clinical practice. This article will outline common technical pitfalls in repositioning operations and propose targeted risk control strategies.

Error 1: Incomplete Repositioning

This is the most common problem. Some doctors only roughly pull the firing pin after firing, without confirming that it is locked in place, before attempting to re-insert the needle. At this time, the internal cutting groove is still in an open or semi-open state, and firing again may result in "empty cutting" or the inclusion of non-target tissue. More seriously, an unlocked needle core may accidentally pop out during insertion, puncturing blood vessels or nerves.

Prevention Measures: Develop the "listen, look, feel" three-step confirmation method-hear a clear locking sound, see the indicator window return to its original position, and feel a significant change in resistance to determine successful repositioning.

Error Two: Excessive Needle Movement During Repositioning

Especially under ultrasound or stereotactic guidance, if the needle is not fixed during repositioning, it can easily cause significant retraction or deviation of the needle tip. This not only causes the next needle insertion to deviate from the lesion but may also tear the mammary duct, leading to hematoma or breast fistula.

Prevention Measures: During repositioning, stabilize the needle hub with one hand and operate the repositioning plug with the other to keep the needle relatively still. If necessary, withdraw the needle to the subcutaneous layer before repositioning.

Error Three: Ignoring Needle Groove Orientation

The orientation of the needle groove may change after repositioning (especially with rotary biopsy guns). If the orientation is not readjusted, the next firing may be directed away from the lesion, leading to sampling failure.

Prevention Measures: After each repositioning, confirm the needle groove orientation through imaging or marking lines, and manually rotate and adjust if necessary.

Mistake 4: Forced Repositioning

• When tissue fragments or blood clots are embedded in the needle groove, forced repositioning can damage the internal mechanical structure and even cause the needle to break.
• Prevention: Stop immediately if resistance increases. Gently rotate the needle or slightly advance and retreat to try to loosen the blockage. If ineffective, replace with a new needle. Violent manipulation is strictly prohibited.

Mistake 5: Reusing Disposable Needles

• Some institutions attempt to save costs by cleaning and reusing disposable biopsy needles. The repositioning mechanism of these needles is often a disposable snap-lock design, which is highly susceptible to failure if forced repositioning is attempted.
• Prevention: Strictly enforce regulations for disposable consumables and establish a consumables traceability system.

Mistake 6: Lack of Teamwork

• In a busy outpatient environment, doctors performing the entire process of needle insertion, firing, repositioning, and sampling alone are prone to errors due to distraction.
• Prevention: Implement a "two-person, four-hands" operation mode, where nurses are responsible for passing instruments, observing patient reactions, and assisting in repositioning confirmation.

Mistake Seven: Ignoring the Impact of Patient Position Changes

• Patient breathing, tension, or positional changes can cause breast tissue displacement. If the needle is not repositioned after repositioning, it may mistakenly enter normal tissue.
• Prevention Measures: After each repositioning, the relative position of the needle tip and the lesion must be reconfirmed via imaging.

From a risk management perspective, medical institutions should incorporate "biopsy needle repositioning procedures" into their quality control system, regularly organizing simulation training and case analyses. Simultaneously, at the product design level, manufacturers can add visual windows for the repositioning status, audio prompts, or tactile feedback devices to reduce the probability of human error.

In short, the repositioning procedure, though seemingly minor, is crucial. Only by acknowledging the risks and standardizing procedures can the clinical value of breast biopsy needles be maximized.